BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

590 related articles for article (PubMed ID: 25994229)

  • 1. Tong-xin-luo capsule for patients with coronary heart disease after percutaneous coronary intervention.
    Mao C; Fu XH; Yuan JQ; Yang ZY; Chung VC; Qin Y; Huang Y; Tam WW; Kwong JS; Xie W; Tang JL
    Cochrane Database Syst Rev; 2015 May; (5):CD010237. PubMed ID: 25994229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Xiongshao for restenosis after percutaneous coronary intervention in patients with coronary heart disease.
    Zheng GH; Liu JP; Chu JF; Mei L; Chen HY
    Cochrane Database Syst Rev; 2013 May; (5):CD009581. PubMed ID: 23728695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tongxinluo (Tong xin luo or Tong-xin-luo) capsule for unstable angina pectoris.
    Wu T; Harrison RA; Chen X; Ni J; Zhou L; Qiao J; Wang Q; Wei J; Xin D; Zheng J
    Cochrane Database Syst Rev; 2006 Oct; 2006(4):CD004474. PubMed ID: 17054205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exercise-based cardiac rehabilitation for coronary heart disease.
    Anderson L; Thompson DR; Oldridge N; Zwisler AD; Rees K; Martin N; Taylor RS
    Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD001800. PubMed ID: 26730878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chinese Herbal Medicines for Restenosis After Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Controlled Trials.
    Wu J; Zhao L; Lin K; Lu L; Luo C
    J Altern Complement Med; 2019 Oct; 25(10):983-992. PubMed ID: 31464515
    [No Abstract]   [Full Text] [Related]  

  • 6. Complete versus culprit-only revascularisation in ST elevation myocardial infarction with multi-vessel disease.
    Bravo CA; Hirji SA; Bhatt DL; Kataria R; Faxon DP; Ohman EM; Anderson KL; Sidi AI; Sketch MH; Zarich SW; Osho AA; Gluud C; Kelbæk H; Engstrøm T; Høfsten DE; Brennan JM
    Cochrane Database Syst Rev; 2017 May; 5(5):CD011986. PubMed ID: 28470696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Periodontal therapy for the management of cardiovascular disease in patients with chronic periodontitis.
    Li C; Lv Z; Shi Z; Zhu Y; Wu Y; Li L; Iheozor-Ejiofor Z
    Cochrane Database Syst Rev; 2014 Aug; (8):CD009197. PubMed ID: 25123257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perioperative beta-blockers for preventing surgery-related mortality and morbidity.
    Blessberger H; Kammler J; Domanovits H; Schlager O; Wildner B; Azar D; Schillinger M; Wiesbauer F; Steinwender C
    Cochrane Database Syst Rev; 2014 Sep; (9):CD004476. PubMed ID: 25233038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Periodontal therapy for the management of cardiovascular disease in patients with chronic periodontitis.
    Li C; Lv Z; Shi Z; Zhu Y; Wu Y; Li L; Iheozor-Ejiofor Z
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD009197. PubMed ID: 29112241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrates for secondary prevention of cardiovascular disease and stroke.
    Wang D; Liu B; Tao W; Hao Z; Liu M
    Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD009580. PubMed ID: 26497361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenosine and verapamil for no-reflow during primary percutaneous coronary intervention in people with acute myocardial infarction.
    Aung Naing K; Li L; Su Q; Wu T
    Cochrane Database Syst Rev; 2013 Jun; (6):CD009503. PubMed ID: 23736949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and Safety of Different Courses of Tongxinluo Capsule as Adjuvant Therapy for Coronary Heart Disease after Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Hui J; Yuan R; Li P; Xin Q; Miao Y; Shen X; Xu F; Cong W
    J Clin Med; 2022 May; 11(11):. PubMed ID: 35683377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A traditional Chinese medicine therapy for coronary heart disease after percutaneous coronary intervention: a meta-analysis of randomized, double-blind, placebo-controlled trials.
    Chen R; Xiao Y; Chen M; He J; Huang M; Hong X; Liu X; Fu T; Zhang J; Chen L
    Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30143584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Exercise after Percutaneous Coronary Intervention on Cardiac Function and Cardiovascular Adverse Events in Patients with Coronary Heart Disease: Systematic Review and Meta-Analysis.
    Zhang H; Chang R
    J Sports Sci Med; 2019 Jun; 18(2):213-222. PubMed ID: 31191090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.
    Xue H; Lu Z; Tang WL; Pang LW; Wang GM; Wong GW; Wright JM
    Cochrane Database Syst Rev; 2015 Jan; 1():CD008170. PubMed ID: 25577154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multi-center randomized double-blind placebo-controlled trial of Xiongshao Capsule in preventing restenosis after percutaneous coronary intervention: a subgroup analysis of senile patients.
    Shang QH; Xu H; Lu XY; Wen C; Shi DZ; Chen KJ
    Chin J Integr Med; 2011 Sep; 17(9):669-74. PubMed ID: 21910067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transradial versus transfemoral approach for diagnostic coronary angiography and percutaneous coronary intervention in people with coronary artery disease.
    Kolkailah AA; Alreshq RS; Muhammed AM; Zahran ME; Anas El-Wegoud M; Nabhan AF
    Cochrane Database Syst Rev; 2018 Apr; 4(4):CD012318. PubMed ID: 29665617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of Huoxue Huayu decoction on restenosis after percutaneous coronary intervention in patients with coronary heart disease: A protocol for systematic review and meta-analysis.
    Hou Y; Li X; Wang X; Dong T; Yang J
    Medicine (Baltimore); 2022 Jan; 101(4):e28677. PubMed ID: 35089215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenosine and verapamil for no-reflow during primary percutaneous coronary intervention in people with acute myocardial infarction.
    Su Q; Nyi TS; Li L
    Cochrane Database Syst Rev; 2015 May; 2015(5):CD009503. PubMed ID: 25985145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tongxinluo capsule as supplementation and cardiovascular endpoint events in patients with coronary heart disease: A systematic review and meta-analysis of randomized, double-blind, placebo-controlled trials.
    Lv J; Liu S; Guo S; Gao J; Song Q; Cui X
    J Ethnopharmacol; 2022 May; 289():115033. PubMed ID: 35091010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.